Troponin I-C Monoclonal Antibody

Troponin I (TnI), along with troponin T (TnT) and troponin C (TnC), is one of 3 subunits that form the troponin complex of the thin filaments of striated muscle. TnI is the inhibitory subunit; blocking actin-myosin interactions and thereby mediating striated muscle relaxation. The TnI subfamily contains three genes: TnI-skeletal-fast-twitch, TnI-skeletal-slow-twitch, and TnI-cardiac. This gene encodes the TnI-cardiac protein and is exclusively expressed in cardiac muscle tissues. Mutations in this gene cause familial hypertrophic cardiomyopathy type 7 (CMH7) and familial restrictive cardiomyopathy (RCM).

Introducing the Troponin I-C Monoclonal Antibody, a cutting-edge product meticulously designed to cater to the needs of the scientific community. This antibody, derived from advanced biotechnological techniques, exhibits exceptional specificity and sensitivity in detecting Troponin I-C, a vital cardiac biomarker.

Crafted with utmost precision, this monoclonal antibody offers unparalleled accuracy in identifying and quantifying Troponin I-C, enabling researchers and clinicians to gain valuable insights into cardiac health. Its high affinity for Troponin I-C ensures reliable and reproducible results, facilitating precise diagnosis and monitoring of cardiac conditions.

The Troponin I-C Monoclonal Antibody boasts an exceptional performance profile, characterized by its low cross-reactivity with other proteins, ensuring minimal interference and enhancing the reliability of experimental outcomes. Its robust nature allows for a wide range of applications, including Western blotting, immunohistochemistry, and enzyme-linked immunosorbent assays (ELISA).

Furthermore, this antibody is manufactured under stringent quality control measures, adhering to the highest industry standards. Each batch undergoes rigorous testing to guarantee consistency, purity, and stability, ensuring optimal performance and reliability in every experiment.

With its remarkable attributes and uncompromising quality, the Troponin I-C Monoclonal Antibody stands as an indispensable tool for researchers and healthcare professionals alike, revolutionizing the field of cardiac diagnostics. Embrace this innovative solution and unlock new possibilities in the realm of cardiovascular research and patient care.